In this issue:
Enfortumab vedotin-related pneumonitis in metastatic UC
Gemcitabine + cisplatin as a bladder-sparing treatment for MIBC
Restaging transurethral resection for high-grade Ta UC
International trends in intravesical chemo with nephroureterectomy
3 vs. 4 cycles of neoadjuvant gemcitabine + cisplatin for MIBC
Gemcitabine/cisplatin vs. gemcitabine/carboplatin + secondline immune checkpoint inhibitors for UC
Pembrolizumab in advanced UC with severe renal dysfunction
Bempegaldesleukin + nivolumab in first-line metastatic UC
FGFRa to stratify response in NMIBC with & without bacillus Calmette-Guérin immunotherapy
Gemcitabine + docetaxel for bacillus Calmette-Guérin-naïve NMIBC
Pembrolizumab in variant UC
Please login below to download this issue (PDF)